Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors
- PMID: 30763444
- DOI: 10.1001/jamaoncol.2018.6694
Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors
Erratum in
-
Omission in Additional Information.JAMA Oncol. 2019 Apr 1;5(4):580. doi: 10.1001/jamaoncol.2019.0708. JAMA Oncol. 2019. PMID: 30973605 No abstract available.
Comment on
-
Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.JAMA Oncol. 2019 Apr 1;5(4):480-489. doi: 10.1001/jamaoncol.2018.6720. JAMA Oncol. 2019. PMID: 30763436 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical